Ankit Gupta, Nicholas Manuelpillai, Sara Lee de Menezes, Saurabh Prakash, Johannes Steffen Kern
{"title":"A rare case of bilateral symmetrical broad-based acquired ungual fibrokeratomas.","authors":"Ankit Gupta, Nicholas Manuelpillai, Sara Lee de Menezes, Saurabh Prakash, Johannes Steffen Kern","doi":"10.1111/ajd.14392","DOIUrl":"https://doi.org/10.1111/ajd.14392","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142816829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cliff Rosendahl, Christine Lee, Sarah Coleman, Aksana Marozava, Blake O'Brien
{"title":"The two-step method of digital follow-up of bland skin lesions is a safe and useful tool in melanoma diagnosis.","authors":"Cliff Rosendahl, Christine Lee, Sarah Coleman, Aksana Marozava, Blake O'Brien","doi":"10.1111/ajd.14390","DOIUrl":"https://doi.org/10.1111/ajd.14390","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Usamah M Afzal, Faisal R Ali, Deemesh Oudit, Roxana Totorean, Gareth Evans, John T Lear
{"title":"Metastatic basal cell carcinomas in Gorlin syndrome-A case series and literature review.","authors":"Usamah M Afzal, Faisal R Ali, Deemesh Oudit, Roxana Totorean, Gareth Evans, John T Lear","doi":"10.1111/ajd.14401","DOIUrl":"https://doi.org/10.1111/ajd.14401","url":null,"abstract":"<p><p>Metastatic basal cell carcinomas (mBCCs) are exceedingly rare, with an estimated variable prevalence rate between 0.003 and 0.55% among all basal cell carcinomas. Although there are hundreds of reported cases of mBCCs, a dearth of evidence exists of mBCCs in patients with Gorlin syndrome-an autosomal dominant genetic disorder. The purpose of this article was to present the first and largest case series of patients with mBCC in Gorlin. A literature review (LR) compares our data with the existing evidence base to underscore the importance of early surveillance, diagnosis and surgical intervention of suspicious lesions as distant metastases significantly reduce survival rates.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Maria Politou, Alexander Stratigos, Electra Nicolaidou
{"title":"Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective study.","authors":"Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Maria Politou, Alexander Stratigos, Electra Nicolaidou","doi":"10.1111/ajd.14396","DOIUrl":"https://doi.org/10.1111/ajd.14396","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charmaine Jieying Tay, Yun Pei Koh, Mark Jean Aan Koh
{"title":"Lower limb nodules with angioinvasive Phaeoacremonium spp. fungus in an immunocompetent host.","authors":"Charmaine Jieying Tay, Yun Pei Koh, Mark Jean Aan Koh","doi":"10.1111/ajd.14398","DOIUrl":"https://doi.org/10.1111/ajd.14398","url":null,"abstract":"<p><p>Phaeohyphomycosis has been described to cause a variety of cutaneous manifestations in both immunocompetent and immunocompromised hosts. We report an unexpected case where an immunocompetent elderly female developed a rare angioinvasive fungal cutaneous infection. She had no known history of inoculation, and her lesions resolved without treatment.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142806074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Malindi Georgia Haggett, Sangho Lee, Francis Yi Xing Lai
{"title":"A systematic review of the efficacy of TYK2 inhibitors in patients with dermatological disease.","authors":"Malindi Georgia Haggett, Sangho Lee, Francis Yi Xing Lai","doi":"10.1111/ajd.14391","DOIUrl":"https://doi.org/10.1111/ajd.14391","url":null,"abstract":"<p><p>This study systematically reviews existing data on the efficacy of Tyrosine Kinase 2 (TYK2) inhibitors in comparison to placebo or standard treatments for therapeutic benefit and improving quality of life in dermatological diseases. Seventeen records representing 13 clinical trials, one matching-adjusted indirect comparison, and one case study were included. Results indicate that Deucravacitinib is superior to placebo, Apremilast and Adalimumab in treating adult patients with moderate-to-severe plaque psoriasis and superior to placebo in the treatment of adults with systemic lupus erythematosus. Comparative investigations on Brepocitinib and Ropsacitinib were more limited. Oral Brepocitinib demonstrated superiority over placebo in managing alopecia areata, and hidradenitis suppurativa. Topical Brepocitinib exhibited superiority over placebo in treating atopic dermatitis, but not plaque psoriasis. Ropsacitinib demonstrated superiority over placebo in the management of plaque psoriasis. Brepocitinib and Ropsacitinib had more side effects than Deucravacitinib.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Australian dermatologists' prescribing behaviours for female androgenetic alopecia.","authors":"Anneliese Willems, Rodney Sinclair","doi":"10.1111/ajd.14393","DOIUrl":"https://doi.org/10.1111/ajd.14393","url":null,"abstract":"<p><p>Female androgenetic alopecia (FAGA) affects approximately half of women during their lifetime and can have significant psychological impact. Despite its prevalence, treatment options have traditionally been limited. In this study, we examined the current prescribing patterns of Australian dermatologists for FAGA (n = 54), including the use of spironolactone, systemic minoxidil, topical minoxidil and combination treatments.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
John Frew, Annika Smith, Pablo Fernandez Penas, Elisabeth Ellis, Peter Foley, Diana Rubel, Erin McMeniman, Gillian Marshman, Helen Saunders, Emma Veysey, Jenny Nicolopolous, Linda Spelman, Kurt Gebauer
{"title":"Australasian hidradenitis suppurativa management guidelines.","authors":"John Frew, Annika Smith, Pablo Fernandez Penas, Elisabeth Ellis, Peter Foley, Diana Rubel, Erin McMeniman, Gillian Marshman, Helen Saunders, Emma Veysey, Jenny Nicolopolous, Linda Spelman, Kurt Gebauer","doi":"10.1111/ajd.14388","DOIUrl":"https://doi.org/10.1111/ajd.14388","url":null,"abstract":"<p><p>Hidradenitis Suppurativa is a burdensome inflammatory skin disease with significant quality of life impact. These management guidelines were developed to direct appropriate clinical management in the Australasian context. A systematic review was used for the basis of the consensus guidelines. Thirteen clinical experts were involved in a modified Delphi consensus process to develop the guidelines and treatment algorithms. Overall management strategies include appropriate severity assessment of disease and comorbidities, multimodal therapy with systemic and local treatments, and evidence-based progression along the therapeutic ladder in the event of inadequate response. Sequential monotherapy with antibiotics and/or single agent therapy is discouraged and aggressive treatment of moderate to severe disease to capture the window of opportunity is highly emphasised. Specific considerations in the setting of disease comorbidities, pregnancy and breastfeeding are also addressed. Overall, the complex nature of HS requires a complex and multimodal therapeutic response with medical, physical and surgical therapies to achieve best patient outcomes.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142692524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Harmeet K Bhullar, Friyana Bhabha, Chris McCormack, H Miles Prince
{"title":"Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.","authors":"Harmeet K Bhullar, Friyana Bhabha, Chris McCormack, H Miles Prince","doi":"10.1111/ajd.14386","DOIUrl":"https://doi.org/10.1111/ajd.14386","url":null,"abstract":"<p><p>Sneddon-Wilkinson (SW) disease is rare condition which typically occurs in the context of a monoclonal immunoglobulin and treatment options have not been well studied. Here we present a case of a 65-year-old female with SW with underlying, otherwise indolent, lymphoplasmacytic lymphoma (LPL) with an IgA paraprotein, who achieved a complete skin remission with the administration of the Bruton Tyrosine Kinase inhibitor (BTKi), acalabrutinib.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}